| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Research (E.C., E.G.), Saint Francis Hospital and Medical Center, Hartford, Connecticut 06105; University of Connecticut School of Medicine (E.C., E.G.), Farmington, Connecticut 06030; and Regeneron Pharmaceuticals, Inc. (A.N.E.), Tarrytown, New York 10591
Correspondence: Address all correspondence and requests for reprints to: Ernesto Canalis, M.D., Department of Research, Saint Francis Hospital and Medical Center, 114 Woodland Street, Hartford, Connecticut 06105-1299. E-mail: ecanalis{at}stfranciscare.org
Skeletal homeostasis is determined by systemic hormones and local factors. Bone morphogenetic proteins (BMP) are unique because they induce the differentiation of mesenchymal cells toward cells of the osteoblastic lineage and also enhance the differentiated function of the osteoblast. However, the activity of BMPs needs to be tempered by intracellular and extracellular antagonists. BMPs bind to specific receptors and signal by phosphorylating the cytoplasmic proteins mothers against decapentaplegic (Smad) 1 and 5, which form heterodimers with Smad 4, and after nuclear translocation regulate transcription. BMP antagonists can be categorized as pseudoreceptors that compete with signaling receptors, inhibitory Smads that block signaling, intracellular binding proteins that bind Smad 1 and 5, and factors that induce ubiquitination and proteolysis of signaling Smads. In addition, a large number of extracellular proteins that bind BMPs and prevent their binding to signaling receptors have emerged. They are the components of the Spemann organizer, noggin, chordin, and follistatin, members of the Dan/Cerberus family, and twisted gastrulation. The antagonists tend to be specific for BMPs and are regulated by BMPs, indicating the existence and need of local feedback mechanisms to temper BMP cellular activities.
This article has been cited by other articles:
 |
|
 |
|
  A. Smerdel-Ramoya, S. Zanotti, L. Stadmeyer, D. Durant, and E. Canalis Skeletal Overexpression of Connective Tissue Growth Factor Impairs Bone Formation and Causes Osteopenia Endocrinology, September 1, 2008; 149(9): 4374 - 4381. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Giustina, G. Mazziotti, and E. Canalis Growth Hormone, Insulin-Like Growth Factors, and the Skeleton Endocr. Rev., August 1, 2008; 29(5): 535 - 559. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Costello, K. Howell, E. Cahill, J. McBryan, M. Konigshoff, O. Eickelberg, S. Gaine, F. Martin, and P. McLoughlin Lung-selective gene responses to alveolar hypoxia: potential role for the bone morphogenetic antagonist gremlin in pulmonary hypertension Am J Physiol Lung Cell Mol Physiol, August 1, 2008; 295(2): L272 - L284. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Lavery, P. Swain, D. Falb, and M. H. Alaoui-Ismaili BMP-2/4 and BMP-6/7 Differentially Utilize Cell Surface Receptors to Induce Osteoblastic Differentiation of Human Bone Marrow-derived Mesenchymal Stem Cells J. Biol. Chem., July 25, 2008; 283(30): 20948 - 20958. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Dai, C. L. Hall, J. Escara-Wilke, A. Mizokami, J. M. Keller, and E. T. Keller Prostate Cancer Induces Bone Metastasis through Wnt-Induced Bone Morphogenetic Protein-Dependent and Independent Mechanisms Cancer Res., July 15, 2008; 68(14): 5785 - 5794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. t. Dijke, C. Krause, D. J. J. de Gorter, C. W.G.M. Lowik, and R. L. van Bezooijen Osteocyte-Derived Sclerostin Inhibits Bone Formation: Its Role in Bone Morphogenetic Protein and Wnt Signaling J. Bone Joint Surg. Am., February 1, 2008; 90(Supplement_1): 31 - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Gazzerro, A. Smerdel-Ramoya, S. Zanotti, L. Stadmeyer, D. Durant, A. N. Economides, and E. Canalis Conditional Deletion of Gremlin Causes a Transient Increase in Bone Formation and Bone Mass J. Biol. Chem., October 26, 2007; 282(43): 31549 - 31557. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Eijken, S. Swagemakers, M. Koedam, C. Steenbergen, P. Derkx, A. G. Uitterlinden, P. J. van der Spek, J. A. Visser, F. H. de Jong, H. A. P. Pols, et al. The activin A-follistatin system: potent regulator of human extracellular matrix mineralization FASEB J, September 1, 2007; 21(11): 2949 - 2960. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Canalis, A. Giustina, and J. P. Bilezikian Mechanisms of Anabolic Therapies for Osteoporosis N. Engl. J. Med., August 30, 2007; 357(9): 905 - 916. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Y. Lee, J.-W. Jeong, J. Wang, L. Ma, J. F. Martin, S. Y. Tsai, J. P. Lydon, and F. J. DeMayo Bmp2 Is Critical for the Murine Uterine Decidual Response Mol. Cell. Biol., August 1, 2007; 27(15): 5468 - 5478. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Rydziel, L. Stadmeyer, S. Zanotti, D. Durant, A. Smerdel-Ramoya, and E. Canalis Nephroblastoma Overexpressed (Nov) Inhibits Osteoblastogenesis and Causes Osteopenia J. Biol. Chem., July 6, 2007; 282(27): 19762 - 19772. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Garimella, M. A. Kacena, S. E. Tague, J. Wang, M. C. Horowitz, and H. C. Anderson Expression of Bone Morphogenetic Proteins and Their Receptors in the Bone Marrow Megakaryocytes of GATA-1low Mice: A Possible Role in Osteosclerosis J. Histochem. Cytochem., July 1, 2007; 55(7): 745 - 752. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Tan, T. Weng, J. Zhang, J. Wang, W. Li, H. Wan, Y. Lan, X. Cheng, N. Hou, H. Liu, et al. Smad4 is required for maintaining normal murine postnatal bone homeostasis J. Cell Sci., July 1, 2007; 120(13): 2162 - 2170. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Xia, P. B. Yu, Y. Sidis, H. Beppu, K. D. Bloch, A. L. Schneyer, and H. Y. Lin Repulsive Guidance Molecule RGMa Alters Utilization of Bone Morphogenetic Protein (BMP) Type II Receptors by BMP2 and BMP4 J. Biol. Chem., June 22, 2007; 282(25): 18129 - 18140. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wang, C. H. Goh, and B. Li p38 Mitogen-Activated Protein Kinase Regulates Osteoblast Differentiation through Osterix Endocrinology, April 1, 2007; 148(4): 1629 - 1637. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ikeya, M. Kawada, H. Kiyonari, N. Sasai, K. Nakao, Y. Furuta, and Y. Sasai Essential pro-Bmp roles of crossveinless 2 in mouse organogenesis Development, November 15, 2006; 133(22): 4463 - 4473. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Schmidl, N. Adam, C. Surmann-Schmitt, T. Hattori, M. Stock, U. Dietz, B. de Crombrugghe, E. Poschl, and K. von der Mark Twisted Gastrulation Modulates Bone Morphogenetic Protein-induced Collagen II and X Expression in Chondrocytes in Vitro and in Vivo J. Biol. Chem., October 20, 2006; 281(42): 31790 - 31800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hartung, K. Bitton-Worms, M. M. Rechtman, V. Wenzel, J. H. Boergermann, S. Hassel, Y. I. Henis, and P. Knaus Different Routes of Bone Morphogenic Protein (BMP) Receptor Endocytosis Influence BMP Signaling Mol. Cell. Biol., October 15, 2006; 26(20): 7791 - 7805. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Zhao, T. Katagiri, H. Toyoda, T. Takada, T. Yanai, T. Fukuda, U.-i. Chung, T. Koike, K. Takaoka, and R. Kamijo Heparin Potentiates the in Vivo Ectopic Bone Formation Induced by Bone Morphogenetic Protein-2 J. Biol. Chem., August 11, 2006; 281(32): 23246 - 23253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Q. Ngo, M. A. Scherer, F. H. Zhou, B. K. Foster, and C. J. Xian Expression of Bone Morphogenic Proteins and Receptors at the Injured Growth Plate Cartilage in Young Rats J. Histochem. Cytochem., August 1, 2006; 54(8): 945 - 954. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Hoffman, K. Garcha, K. Karamboulas, M. F. Cowan, L. M. Drysdale, W. A. Horton, and T. M. Underhill BMP action in skeletogenesis involves attenuation of retinoid signaling J. Cell Biol., July 3, 2006; 174(1): 101 - 113. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Seeherman, K. Azari, S. Bidic, L. Rogers, X. J. Li, J. O. Hollinger, and J. M. Wozney rhBMP-2 Delivered in a Calcium Phosphate Cement Accelerates Bridging of Critical-Sized Defects in Rabbit Radii J. Bone Joint Surg. Am., July 1, 2006; 88(7): 1553 - 1565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. T. Fritz, S. Jiang, J. Xu, and M. B. Rogers A Polymorphism in a Conserved Posttranscriptional Regulatory Motif Alters Bone Morphogenetic Protein 2 (BMP2) RNA:Protein Interactions Mol. Endocrinol., July 1, 2006; 20(7): 1574 - 1586. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yamamoto, N. Udagawa, S. Matsuura, Y. Nakamichi, H. Horiuchi, A. Hosoya, M. Nakamura, H. Ozawa, K. Takaoka, J. M. Penninger, et al. Osteoblasts Provide a Suitable Microenvironment for the Action of Receptor Activator of Nuclear Factor-{kappa}B Ligand Endocrinology, July 1, 2006; 147(7): 3366 - 3374. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Harrison, K. L. Chan, and D. M. Robertson Activin-A Binds Follistatin and Type II Receptors through Overlapping Binding Sites: Generation of Mutants with Isolated Binding Activities Endocrinology, June 1, 2006; 147(6): 2744 - 2753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hua, Y.-Q. Zhang, S. Dabernat, M. Kritzik, D. Dietz, L. Sterling, and N. Sarvetnick BMP4 Regulates Pancreatic Progenitor Cell Expansion through Id2 J. Biol. Chem., May 12, 2006; 281(19): 13574 - 13580. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Yamada, Y. Ozawa, M. Tomoeda, R. Matoba, K. Matsubara, and S. Murakami Regulation of PLAP-1 Expression in Periodontal Ligament Cells. J. Dent. Res., May 1, 2006; 85(5): 447 - 451. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Yamada, Y. Ozawa, M. Tomoeda, R. Matoba, K. Matsubara, and S. Murakami Regulation of PLAP-1 Expression in Periodontal Ligament Cells Journal of Dental Research, May 1, 2006; 85(5): 447 - 451. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-H. W. Lau, S. Kapur, C. Kesavan, and D. J. Baylink Up-regulation of the Wnt, Estrogen Receptor, Insulin-like Growth Factor-I, and Bone Morphogenetic Protein Pathways in C57BL/6J Osteoblasts as Opposed to C3H/HeJ Osteoblasts in Part Contributes to the Differential Anabolic Response to Fluid Shear J. Biol. Chem., April 7, 2006; 281(14): 9576 - 9588. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Noda BMP and Its Antagonists IBMS BoneKEy, April 1, 2006; 3(4): 5 - 11. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Haque, M. Mandu-Hrit, F. Rauch, D. Lauzier, M. Tabrizian, and R. C. Hamdy Immunohistochemical Localization of Bone Morphogenetic Protein-signaling Smads during Long-bone Distraction Osteogenesis J. Histochem. Cytochem., April 1, 2006; 54(4): 407 - 415. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Deregowski, E. Gazzerro, L. Priest, S. Rydziel, and E. Canalis Notch 1 Overexpression Inhibits Osteoblastogenesis by Suppressing Wnt/beta-Catenin but Not Bone Morphogenetic Protein Signaling J. Biol. Chem., March 10, 2006; 281(10): 6203 - 6210. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G Tardif, J-P Pelletier, D Hum, C Boileau, N Duval, and J Martel-Pelletier Differential regulation of the bone morphogenic protein antagonist chordin in human normal and osteoarthritic chondrocytes Ann Rheum Dis, February 1, 2006; 65(2): 261 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Manolagas Choreography from the Tomb: An Emerging Role of Dying Osteocytes in the Purposeful, and Perhaps Not So Purposeful, Targeting of Bone Remodeling IBMS BoneKEy, January 1, 2006; 3(1): 5 - 14. [Full Text] [PDF]
|
|
|
|
|
|
H. Seeherman, R. Li, M. Bouxsein, H. Kim, X. J. Li, E. A. Smith-Adaline, M. Aiolova, and J. M. Wozney rhBMP-2/Calcium Phosphate Matrix Accelerates Osteotomy-Site Healing in a Nonhuman Primate Model at Multiple Treatment Times and Concentrations J. Bone Joint Surg. Am., January 1, 2006; 88(1): 144 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. van Bezooijen, S. E. Papapoulos, N. A. Hamdy, P. ten Dijke, and C. W. Lowik Control of Bone Formation by Osteocytes? Lessons from the Rare Skeletal Disorders Sclerosteosis and van Buchem Disease IBMS BoneKEy, December 1, 2005; 2(12): 33 - 38. [Full Text] [PDF]
|
|
|
|
|
|
T. S. Hussein, D. A. Froiland, F. Amato, J. G. Thompson, and R. B. Gilchrist Oocytes prevent cumulus cell apoptosis by maintaining a morphogenic paracrine gradient of bone morphogenetic proteins J. Cell Sci., November 15, 2005; 118(22): 5257 - 5268. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Nakashima, T. Katagiri, and M. Tamura Cross-talk between Wnt and Bone Morphogenetic Protein 2 (BMP-2) Signaling in Differentiation Pathway of C2C12 Myoblasts J. Biol. Chem., November 11, 2005; 280(45): 37660 - 37668. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Bellido, A. A. Ali, I. Gubrij, L. I. Plotkin, Q. Fu, C. A. O'Brien, S. C. Manolagas, and R. L. Jilka Chronic Elevation of Parathyroid Hormone in Mice Reduces Expression of Sclerostin by Osteocytes: A Novel Mechanism for Hormonal Control of Osteoblastogenesis Endocrinology, November 1, 2005; 146(11): 4577 - 4583. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Janssens, P. ten Dijke, S. Janssens, and W. Van Hul Transforming Growth Factor-{beta}1 to the Bone Endocr. Rev., October 1, 2005; 26(6): 743 - 774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Giuliani, S. Colla, F. Morandi, M. Lazzaretti, R. Sala, S. Bonomini, M. Grano, S. Colucci, M. Svaldi, and V. Rizzoli Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation Blood, October 1, 2005; 106(7): 2472 - 2483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Dai, J. Keller, J. Zhang, Y. Lu, Z. Yao, and E. T. Keller Bone Morphogenetic Protein-6 Promotes Osteoblastic Prostate Cancer Bone Metastases through a Dual Mechanism Cancer Res., September 15, 2005; 65(18): 8274 - 8285. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Gazzerro, V. Deregowski, S. Vaira, and E. Canalis Overexpression of Twisted Gastrulation Inhibits Bone Morphogenetic Protein Action and Prevents Osteoblast Cell Differentiation in Vitro Endocrinology, September 1, 2005; 146(9): 3875 - 3882. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Kalajzic, A. Staal, W.-P. Yang, Y. Wu, S. E. Johnson, J. H. M. Feyen, W. Krueger, P. Maye, F. Yu, Y. Zhao, et al. Expression Profile of Osteoblast Lineage at Defined Stages of Differentiation J. Biol. Chem., July 1, 2005; 280(26): 24618 - 24626. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.F. Termaat, F.C. Den Boer, F.C. Bakker, P. Patka, and H.J.Th.M. Haarman Bone Morphogenetic Proteins. Development and Clinical Efficacy in the Treatment of Fractures and Bone Defects J. Bone Joint Surg. Am., June 1, 2005; 87(6): 1367 - 1378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Galindo, J. Pratap, D. W. Young, H. Hovhannisyan, H.-J. Im, J.-Y. Choi, J. B. Lian, J. L. Stein, G. S. Stein, and A. J. van Wijnen The Bone-specific Expression of Runx2 Oscillates during the Cell Cycle to Support a G1-related Antiproliferative Function in Osteoblasts J. Biol. Chem., May 27, 2005; 280(21): 20274 - 20285. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Yang, Y. Lu, I. Kalajzic, D. Guo, M. A. Harris, J. Gluhak-Heinrich, S. Kotha, L. F. Bonewald, J. Q. Feng, D. W. Rowe, et al. Dentin Matrix Protein 1 Gene Cis-regulation: USE IN OSTEOCYTES TO CHARACTERIZE LOCAL RESPONSES TO MECHANICAL LOADING IN VITRO AND IN VIVO J. Biol. Chem., May 27, 2005; 280(21): 20680 - 20690. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Canalis The Fate of Circulating Osteoblasts N. Engl. J. Med., May 12, 2005; 352(19): 2014 - 2016. [Full Text] [PDF]
|
|
|
|
|
|
C. Glister, S. L. Richards, and P. G. Knight Bone Morphogenetic Proteins (BMP) -4, -6, and -7 Potently Suppress Basal and Luteinizing Hormone-Induced Androgen Production by Bovine Theca Interna Cells in Primary Culture: Could Ovarian Hyperandrogenic Dysfunction Be Caused by a Defect in Thecal BMP Signaling? Endocrinology, April 1, 2005; 146(4): 1883 - 1892. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-W. Luo, E. M. Dewey, S. Sudo, J. Ewer, S. Y. Hsu, H.-W. Honegger, and A. J. W. Hsueh Bursicon, the insect cuticle-hardening hormone, is a heterodimeric cystine knot protein that activates G protein-coupled receptor LGR2 PNAS, February 22, 2005; 102(8): 2820 - 2825. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Gazzerro, R. C. Pereira, V. Jorgetti, S. Olson, A. N. Economides, and E. Canalis Skeletal Overexpression of Gremlin Impairs Bone Formation and Causes Osteopenia Endocrinology, February 1, 2005; 146(2): 655 - 665. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Bostrom, A. F. Zebboudj, Y. Yao, T. S. Lin, and A. Torres Matrix GLA Protein Stimulates VEGF Expression through Increased Transforming Growth Factor-{beta}1 Activity in Endothelial Cells J. Biol. Chem., December 17, 2004; 279(51): 52904 - 52913. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Q. Pirih, A. Tang, I. C. Ozkurt, J. M. Nervina, and S. Tetradis Nuclear Orphan Receptor Nurr1 Directly Transactivates the Osteocalcin Gene in Osteoblasts J. Biol. Chem., December 17, 2004; 279(51): 53167 - 53174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Panepucci, J. L.C. Siufi, W. A. Silva Jr., R. Proto-Siquiera, L. Neder, M. Orellana, V. Rocha, D. T. Covas, and M. A. Zago Comparison of Gene Expression of Umbilical Cord Vein and Bone Marrow-Derived Mesenchymal Stem Cells Stem Cells, December 1, 2004; 22(7): 1263 - 1278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Haudenschild, S. M. Palmer, T. A. Moseley, Z. You, and A. H. Reddi Bone Morphogenetic Protein (BMP)-6 Signaling and BMP Antagonist Noggin in Prostate Cancer Cancer Res., November 15, 2004; 64(22): 8276 - 8284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. I. Reinhold, M. Abe, R. M. Kapadia, Z. Liao, and M. C. Naski FGF18 Represses Noggin Expression and Is Induced by Calcineurin J. Biol. Chem., September 10, 2004; 279(37): 38209 - 38219. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Ganss and A. Jheon ZINC FINGER TRANSCRIPTION FACTORS IN SKELETAL DEVELOPMENT Crit. Rev. Oral. Biol. Med., September 1, 2004; 15(5): 282 - 297. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Ganss and A. Jheon ZINC FINGER TRANSCRIPTION FACTORS IN SKELETAL DEVELOPMENT Critical Reviews in Oral Biology & Medicine, September 1, 2004; 15(5): 282 - 297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Seeherman, M. Bouxsein, H. Kim, R. Li, X. J. Li, M. Aiolova, and J. M. Wozney Recombinant Human Bone Morphogenetic Protein-2 Delivered in an Injectable Calcium Phosphate Paste Accelerates Osteotomy-Site Healing in a Nonhuman Primate Model J. Bone Joint Surg. Am., September 1, 2004; 86(9): 1961 - 1972. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Winkler, C. Yu, J. C. Geoghegan, E. W. Ojala, J. E. Skonier, D. Shpektor, M. K. Sutherland, and J. A. Latham Noggin and Sclerostin Bone Morphogenetic Protein Antagonists Form a Mutually Inhibitory Complex J. Biol. Chem., August 27, 2004; 279(35): 36293 - 36298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Pangas, C. J. Jorgez, and M. M. Matzuk Growth Differentiation Factor 9 Regulates Expression of the Bone Morphogenetic Protein Antagonist Gremlin J. Biol. Chem., July 30, 2004; 279(31): 32281 - 32286. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
|
